Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

beta2 adrenergic agonists in acute lung injury? The heart of the matter.

Lee JW.

Crit Care. 2009;13(6):1011. doi: 10.1186/cc8171. Epub 2009 Dec 7.

2.
3.

β2 agonist for the treatment of acute lung injury: a systematic review and meta-analysis.

Singh B, Tiwari AK, Singh K, Singh SK, Ahmed A, Erwin PJ, Franco PM.

Respir Care. 2014 Feb;59(2):288-96. doi: 10.4187/respcare.02571. Epub 2013 Jun 18. Review.

4.

Emerging pharmacological therapies for prevention and early treatment of acute lung injury.

Ortiz-Diaz E, Festic E, Gajic O, Levitt JE.

Semin Respir Crit Care Med. 2013 Aug;34(4):448-58. doi: 10.1055/s-0033-1351118. Epub 2013 Aug 11. Review.

PMID:
23934714
5.

Mechanisms of beta-receptor stimulation-induced improvement of acute lung injury and pulmonary edema.

Groshaus HE, Manocha S, Walley KR, Russell JA.

Crit Care. 2004 Aug;8(4):234-42. Epub 2004 May 25. Review.

6.

The beta-agonist lung injury trial (BALTI): a randomized placebo-controlled clinical trial.

Perkins GD, McAuley DF, Thickett DR, Gao F.

Am J Respir Crit Care Med. 2006 Feb 1;173(3):281-7. Epub 2005 Oct 27.

PMID:
16254268
7.

Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis.

Tang BM, Craig JC, Eslick GD, Seppelt I, McLean AS.

Crit Care Med. 2009 May;37(5):1594-603. doi: 10.1097/CCM.0b013e31819fb507. Review.

PMID:
19325471
8.

Beta-adrenergic agonist therapy as a potential treatment for acute lung injury.

Matthay MA, Abraham E.

Am J Respir Crit Care Med. 2006 Feb 1;173(3):254-5. No abstract available.

PMID:
16436367
9.

Recombinant angiotensin-converting enzyme 2 improves pulmonary blood flow and oxygenation in lipopolysaccharide-induced lung injury in piglets.

Treml B, Neu N, Kleinsasser A, Gritsch C, Finsterwalder T, Geiger R, Schuster M, Janzek E, Loibner H, Penninger J, Loeckinger A.

Crit Care Med. 2010 Feb;38(2):596-601. doi: 10.1097/CCM.0b013e3181c03009.

PMID:
19851091
10.
11.

Continuous dose furosemide as a therapeutic approach to acute respiratory distress syndrome (ARDS).

Reising CA, Chendrasekhar A, Wall PL, Paradise NF, Timberlake GA, Moorman DW.

J Surg Res. 1999 Mar;82(1):56-60.

PMID:
10068526
12.

Effect of neutrophil elastase inhibitor (sivelestat sodium) in the treatment of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): a systematic review and meta-analysis.

Iwata K, Doi A, Ohji G, Oka H, Oba Y, Takimoto K, Igarashi W, Gremillion DH, Shimada T.

Intern Med. 2010;49(22):2423-32. Epub 2010 Nov 15. Review.

13.

Inhaled beta-2 agonist salbutamol and acute lung injury: an association with improvement in acute lung injury.

Manocha S, Gordon AC, Salehifar E, Groshaus H, Walley KR, Russell JA.

Crit Care. 2006 Feb;10(1):R12.

14.

Pharmacologic therapies on the horizon for acute lung injury/acute respiratory distress syndrome.

Jacobson JR.

J Investig Med. 2009 Dec;57(8):870-3. doi: 10.2310/JIM.0b013e3181c04681. Review.

PMID:
19820408
15.
16.

Pharmacotherapy for acute respiratory distress syndrome.

Shafeeq H, Lat I.

Pharmacotherapy. 2012 Oct;32(10):943-57. doi: 10.1002/j.1875-9114.2012.01115. Review.

PMID:
23033233
17.

Beta-2-agonist treatment as a potential therapy for acute inhalational lung injury.

Wiener-Kronish JP, Matthay MA.

Crit Care Med. 2006 Jun;34(6):1841-2. No abstract available.

PMID:
16714996
18.

Pharmacogenetic treatment of acute respiratory distress syndrome.

Hooper MH, Bernard GR.

Minerva Anestesiol. 2011 Jun;77(6):624-36. Review.

19.

Aerosolized beta(2)-adrenergic agonists achieve therapeutic levels in the pulmonary edema fluid of ventilated patients with acute respiratory failure.

Atabai K, Ware LB, Snider ME, Koch P, Daniel B, Nuckton TJ, Matthay MA.

Intensive Care Med. 2002 Jun;28(6):705-11. Epub 2002 May 17.

PMID:
12107675
20.

Beta2 adrenergic agonist therapy may enhance alveolar epithelial repair in patients with acute lung injury.

Matthay MA, Lee J.

Thorax. 2008 Mar;63(3):189-90. doi: 10.1136/thx.2007.086256. No abstract available.

PMID:
18308954

Supplemental Content

Support Center